Literature DB >> 18676520

Growth of children on classical and medium-chain triglyceride ketogenic diets.

Elizabeth G Neal1, Hannah M Chaffe, Nicole Edwards, Margaret S Lawson, Ruby H Schwartz, J Helen Cross.   

Abstract

OBJECTIVE: The objectives of this study were to examine growth in children on classical and medium-chain triglyceride ketogenic diets and to investigate any association between growth and calorie or protein intake.
METHODS: Weight, height, and BMI z scores were recorded for children who were initiated on 1 of 2 ketogenic diets at baseline and after 3, 6, and 12 months, if continued. Mean calorie and protein intakes during treatment were calculated for children who completed 12 months on the diet. Changes in growth were compared between the 2 diets, and the association between growth and dietary intake was examined.
RESULTS: Seventy-five children provided growth data. Weight z scores decreased significantly between baseline and 3, 6, and 12 months; height z scores showed no change at 3 months but decreased significantly by 6 and 12 months. This was more significant in the younger and ambulatory children. Subdivision according to diet type showed weight z scores to decrease significantly in the medium-chain triglyceride group only at 3 and 6 months and in both groups at 12 months. Height z scores decreased significantly in both groups by 6 and 12 months. Forty children completed 12 months of treatment; in this group, the slopes of best-fit regression lines of serial z-score measures were used to represent growth trend. There were no significant differences in mean slope between classical and medium-chain triglyceride diet groups for weight, height, or BMI. There was no significant difference in mean calorie intake during the 12 months between the 2 diets, but the medium-chain triglyceride group had significantly higher protein intake. There was no significant correlation between calorie or protein intakes and the slope of the best-fit line for weight, height, or BMI.
CONCLUSIONS: Both weight and height z scores decreased during diet treatment. By 12 months, there was no difference in outcome between classical and medium-chain triglyceride protocols despite the increased protein in the latter diet.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18676520     DOI: 10.1542/peds.2007-2410

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  12 in total

Review 1.  Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies.

Authors:  Qian-Yun Cai; Zhong-Jie Zhou; Rong Luo; Jing Gan; Shi-Ping Li; De-Zhi Mu; Chao-Min Wan
Journal:  World J Pediatr       Date:  2017-07-12       Impact factor: 2.764

2.  Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet.

Authors:  Julie B Milder; Li-Ping Liang; Manisha Patel
Journal:  Neurobiol Dis       Date:  2010-05-31       Impact factor: 5.996

Review 3.  Dietary therapies for epilepsy: future research.

Authors:  Sudha K Kessler; Elizabeth G Neal; Carol S Camfield; Eric H Kossoff
Journal:  Epilepsy Behav       Date:  2011-03-26       Impact factor: 2.937

Review 4.  Hypothalamic hormones and metabolism.

Authors:  Liu Lin Thio
Journal:  Epilepsy Res       Date:  2012-07       Impact factor: 3.045

Review 5.  Ketogenic diets: new advances for metabolism-based therapies.

Authors:  Eric H Kossoff; Adam L Hartman
Journal:  Curr Opin Neurol       Date:  2012-04       Impact factor: 5.710

6.  Long-term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy.

Authors:  Veronique Groleau; Joan I Schall; Virginia A Stallings; Christina A Bergqvist
Journal:  Dev Med Child Neurol       Date:  2014-04-20       Impact factor: 5.449

7.  The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

Authors:  David N Ruskin; Susan A Masino
Journal:  Front Neurosci       Date:  2012-03-26       Impact factor: 4.677

8.  Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group.

Authors:  Eric H Kossoff; Beth A Zupec-Kania; Stéphane Auvin; Karen R Ballaban-Gil; A G Christina Bergqvist; Robyn Blackford; Jeffrey R Buchhalter; Roberto H Caraballo; J Helen Cross; Maria G Dahlin; Elizabeth J Donner; Orkide Guzel; Rana S Jehle; Joerg Klepper; Hoon-Chul Kang; Danielle A Lambrechts; Y M Christiana Liu; Janak K Nathan; Douglas R Nordli; Heidi H Pfeifer; Jong M Rho; Ingrid E Scheffer; Suvasini Sharma; Carl E Stafstrom; Elizabeth A Thiele; Zahava Turner; Maria M Vaccarezza; Elles J T M van der Louw; Pierangelo Veggiotti; James W Wheless; Elaine C Wirrell
Journal:  Epilepsia Open       Date:  2018-05-21

9.  Ghrelin Plasma Levels After 1 Year of Ketogenic Diet in Children With Refractory Epilepsy.

Authors:  Maddalena Marchiò; Laura Roli; Chiara Lucchi; Anna Maria Costa; Matteo Borghi; Lorenzo Iughetti; Tommaso Trenti; Azzurra Guerra; Giuseppe Biagini
Journal:  Front Nutr       Date:  2019-07-24

10.  Ketogenic Diet in Refractory Childhood Epilepsy: Starting With a Liquid Formulation in an Outpatient Setting.

Authors:  Amerins Weijenberg; Margreet van Rijn; Petra M C Callenbach; Tom J de Koning; Oebele F Brouwer
Journal:  Child Neurol Open       Date:  2018-05-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.